MORGAN ROBBINS: Open Payments
NPI 1386314342 · SHELBY, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,158 in 66 payments from 14 companies in 2025. Trend: 2023 $735 · 2024 $833 · 2025 $1,158
Food & beverage: $1,158
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 28 | $303 |
| AstraZeneca Pharmaceuticals LP | 6 | $189 |
| Novo Nordisk Inc | 9 | $170 |
| Axsome Therapeutics, Inc. | 4 | $128 |
| Lilly USA, LLC | 3 | $66 |
| GlaxoSmithKline, LLC. | 3 | $59 |
| Alkermes, Inc. | 3 | $58 |
| Exact Sciences Corporation | 3 | $46 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $35 |
| Astellas Pharma US Inc | 1 | $29 |
Products named: QULIPTA, Auvelity, BREZTRI, VRAYLAR, FARXIGA, MOUNJARO, Rybelsus, ARISTADA.
Industry payments across NC — which companies pay providers there.
